• Posted by:
• HIL Applied Medical
• No comments

HIL to present at the 2014 MDDMI conference, Tel-Aviv, Israel Join us at the 5th MDDMI Conference and Exhibition at Tel-Aviv’s David Intercontinental Hotel, December 10 2014, for the latest updates on HIL by its CEO, Mr. Sagi Brink-Danan.

• Posted by:
• HIL Applied Medical
• No comments

HIL participates in the 2014 OurCrowd Global Investor Summit CEO Sagi Brink-Danan presented HIL Applied Medical and held a roundtable discussion and meeting at the recent OurCrowd Global Investor Summit 2014, in Jerusalem, December 9. Billed as the “world’s largest equity crowdfunding …

• Posted by:
• HIL Applied Medical
• No comments

HIL key patent granted in Japan HIL’s Japanese patent application number 2011-541715, regarding a System for Fast Ion Generation and a Method Thereof, was allowed (granted) today. Coming on the heels of a recent patent issuance in the US, this …

• Posted by:
• HIL Applied Medical
• No comments

HIL scientists publish latest results in peer-reviewed physics journal HPLSE Cambridge University Press’ journal HPLSE (High Power Laser Science and Engineering) today published a paper by HIL founders Prof. Arie Zigler and Dr. Shmuel Eisenmann, HIL physicist Mr. Eyal Gad …

• Posted by:
• HIL Applied Medical
• No comments

HIL wins multi-million Dollar support from Israeli Government The Israeli Ministry of Economy, Office of the Chief Scientist (OCS), has today approved HIL’s ambitious, multi-million Dollar R&D plan. The OCS will financially support 60% of the approved budget. In addition …

• Posted by:
• HIL Applied Medical
• No comments

Globes dedicates its weekly startup profile to HIL Globes, Israel’s leading business news publication, today featured a profile of HIL Applied Medical. Columnist Gali Weinreb (One Start-Up A Week) spent time with HIL’s Shmuel Eisenmann and Sagi Brink-Danan to learn …

• Posted by:
• HIL Applied Medical
• No comments

HIL profiled in Start-Up Magazine HIL’s Shmuel Eisenmann and Sagi Brink-Danan spoke with Elsevier’s Bob Kronemyer about the promise of proton beam cancer radiotherapy, its current limitations, and the company’s vision to bring it to every eligible patient. Elsevier Business …

• Posted by:
• HIL Applied Medical
• No comments

HIL in the news – Israel Today HIL Co-founder Prof. Arie Zigler, and the technology the company is developing, were featured today in Israel’s newspaper Israel Today. “HIL’s most recent experimental results, as well as other advances in the fields …

• Posted by:
• HIL Applied Medical
• No comments

Mr. Yves Jongen joins HIL’s Advisory Board Yves Jongen is Chief Research Officer for Ion Beam Applications. After founding IBA in 1986, he served as general manager and co-general manager of the company until March 2000, when he assumed his …

• Posted by:
• HIL Applied Medical
• No comments

Prof. Zelig Tochner joins HIL’s Advisory Board Prof. Tochner is the medical director of the Roberts Proton Therapy Center at the University of Pennsylvania Medical Center, one of the world’s largest proton therapy facilities. He is also the chief of …